Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following regulatory approval. This offers a convenient option for adults with type 2 diabetes. Mounjaro, a dual GIP and GLP-1 receptor agonist, aids in blood sugar control and weight management, addressing a significant need in a country with a large diabetic population.
Categories
Finance/Money
Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in India
